Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
We report response in anaemia and wellbeing of a lady with chronic renal disease treated with recombinant human erythropoietin 5000 units thrice weekly. Without any blood transfusions, the patient's haematocrit improved (20% to 35%) and a subjective improvement in wellbeing and appetite was noted. This drug seems to be a breakthrough in the management of anaemia of chronic renal diseases, including end stage renal disease, avoiding the risks of repeated blood transfusions.